Target intelligence / Profile preview

Cytochrome P450 family 4 subfamily F member 23, pseudogene (CYP4F23P)

Target
CYP4F23P
Molecular classification
Other (specifically, pseudogene of the cytochrome P450 superfamily)
01

Overview

Cytochrome P450 family 4 subfamily F member 23, pseudogene (CYP4F23P), is a non-functional genomic sequence derived from the cytochrome P450 family 4 subfamily F member 23 gene. It belongs to the expansive cytochrome P450 (CYP) gene superfamily, which contains functional genes coding for enzymes involved in the metabolism of xenobiotics and endogenous substrates, as well as a large number of pseudogenes like CYP4F23P that have lost the ability to code for functional proteins through evolutionary processes. As a pseudogene, CYP4F23P has no known biological function, does not produce a protein, and has no established relevance as a drug target, biomarker, or disease gene[1][3][4][5][7]. Key clarifications: - Is_target: False. Not a therapeutic or pharmacological target, as it does not encode a functional receptor, enzyme, or transporter[3][4][5][7]. - Is_incorrect: True. CYP4F23P is not a functional molecular target; queries about its druggability, mechanisms, or disease relevance are based on a nonfunctional locus[3][4][5][7]. - Aliases: No widely used aliases beyond systematic nomenclature and database-specific codes[3]. Note: While the functional CYP4F family members (e.g., CYP4F2, CYP4F3) are enzymes with roles in fatty acid metabolism and potential pharmacological interest[2], CYP4F23P itself is classified specifically as a pseudogene, has no known product, and thus is not relevant for drug targeting or mechanistic studies[3][4][7].

Other names
CYP4F23Pcytochrome P450, family 4, subfamily F, polypeptide 23, pseudogene
02

Mechanism of action

None applicable (no functional product to target)

03

Biological functions

None (It is a pseudogene and not a functional gene/protein)
04

Disease associations

None established (no functional protein, thus no direct role in disease)
05

Safety considerations

None (not a therapeutic target, so not subject to pharmacological safety concerns)
06

Interacting drugs

None (as it does not encode a functional protein, no drugs directly interact)
07

Biomarkers

None established (not used as a clinical biomarker)

Beyond the preview

Go deeper on Cytochrome P450 family 4 subfamily F member 23, pseudogene (CYP4F23P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 family 4 subfamily F member 23, pseudogene (CYP4F23P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call